Clinical Trial Update: Human Rhinovirus Infection and Airway Remodeling Mediators [NA]

View source ↗

Summary

The clinical trial evaluating human rhinovirus infection and airway remodeling mediators in asthma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma | NA | Status: TERMINATED